Location of Repository

Drugs for exceptionally rare diseases: a commentary on Hughes et al

By K. Claxton, C. McCabe, A. Tsuchiya and J. Raftery

Abstract

Recently in this journal, Hughes and colleagues discussed special funding status to ultra-orphan drugs. They concluded that there should be a uniform policy for the provision of orphan drugs across Europe; that complete restriction was impractical, and that UK policy should aspire to the values of the EU directive on orphan drugs. We critically assess these arguments, demonstrating that they failed to justify special status for treatments for rare diseases

Publisher: QJM
Year: 2006
OAI identifier: oai:eprints.whiterose.ac.uk:11032

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.